 <h1>Corzide Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>bendroflumethiazide / nadolol</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about bendroflumethiazide / nadolol. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Corzide.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to bendroflumethiazide/nadolol: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred. The dosage should be gradually reduced over 1 to 2 weeks, and the patient should be carefully monitored when discontinuing chronic therapy, particularly in patients with ischemic heart disease. If angina markedly worsens or acute coronary insufficiency develops, nadolol should be reinstated promptly, at least temporarily, and other measures appropriate for the management of unstable angina should be taken. Patients should be warned against interruption or discontinuation of therapy without the physician's advice.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, bendroflumethiazide / nadolol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking bendroflumethiazide / nadolol:</p><p>
<i>Less common</i>
</p><ul>
<li>Blurred vision</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>chest pain or discomfort</li>
<li>confusion</li>
<li>cough</li>
<li>difficulty breathing</li>
<li>dilated neck veins</li>
<li>dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly</li>
<li>extreme fatigue</li>
<li>irregular breathing</li>
<li>lightheadedness, dizziness, or fainting</li>
<li>noisy breathing</li>
<li>paleness or cold feeling in fingertips and toes</li>
<li>shortness of breath</li>
<li>slow or irregular heartbeat</li>
<li>slurred speech</li>
<li>sweating</li>
<li>swelling of face, fingers, feet, or lower legs</li>
<li>tightness in chest</li>
<li>tingling or pain in fingers or toes when exposed to cold</li>
<li>unusual tiredness or weakness</li>
<li>weight gain</li>
<li>wheezing</li>
</ul><p>
<i>Incidence not determined</i>
</p><ul>
<li>Back or leg pains</li>
<li>black, tarry stools</li>
<li>bleeding gums</li>
<li>bloating</li>
<li>blood in urine or stools</li>
<li>chills</li>
<li>clay-colored stools</li>
<li>cloudy urine</li>
<li>cold sweats</li>
<li>constipation</li>
<li>coughing up blood</li>
<li>dark urine</li>
<li>difficulty swallowing</li>
<li>drowsiness</li>
<li>dry mouth</li>
<li>fast heartbeat</li>
<li>fever</li>
<li>flushed, dry skin</li>
<li>fruit-like breath odor</li>
<li>general body swelling</li>
<li>general feeling of discomfort or illness</li>
<li>general tiredness and weakness</li>
<li>headache</li>
<li>hives</li>
<li>hoarseness</li>
<li>increased hunger</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>indigestion</li>
<li>joint pain, stiffness, or swelling</li>
<li>light-colored stools</li>
<li>loss of appetite</li>
<li>lower back or side pain</li>
<li>muscle tremors</li>
<li>nausea and vomiting</li>
<li>nosebleeds</li>
<li>pain in muscles</li>
<li>painful or difficult urination</li>
<li>pains in stomach, side, or abdomen, possibly radiating to the back</li>
<li>pale skin</li>
<li>pinpoint red spots on skin</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>rapid, deep breathing</li>
<li>rash</li>
<li>redness, soreness, or itching skin</li>
<li>restlessness</li>
<li>skin rash</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on lips or in mouth</li>
<li>sores, welting or blisters</li>
<li>stomach cramps</li>
<li>sugar in the urine</li>
<li>swollen or painful glands</li>
<li>tenderness of salivary glands</li>
<li>thickening of bronchial secretions</li>
<li>troubled breathing</li>
<li>unpleasant breath odor</li>
<li>unusual bleeding or bruising</li>
<li>unusual weight loss</li>
<li>upper right abdominal pain</li>
<li>vomiting of blood</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking bendroflumethiazide / nadolol:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Change in consciousness</li>
<li>decreased urination</li>
<li>diarrhea</li>
<li>fast, slow, or shallow breathing</li>
<li>gas</li>
<li>heartburn</li>
<li>increase in heart rate</li>
<li>increased sweating</li>
<li>indigestion</li>
<li>loss of consciousness</li>
<li>low blood pressure</li>
<li>muscle cramps</li>
<li>numbness, tingling, pain, or weakness in hands or feet</li>
<li>pale or blue lips, fingernails, or skin</li>
<li>seizures</li>
<li>sunken eyes</li>
<li>trembling</li>
<li>unusual drowsiness, dullness, or feeling of sluggishness</li>
<li>unusual paleness</li>
<li>weakness and heaviness of legs</li>
<li>wrinkled skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of bendroflumethiazide / nadolol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Change in behavior</li>
<li>continuing ringing or buzzing or other unexplained noise in ears</li>
<li>decreased interest in sexual intercourse</li>
<li>dry eyes or skin</li>
<li>excess air or gas in stomach or intestines</li>
<li>hair loss, thinning of hair</li>
<li>hearing loss</li>
<li>inability to have or keep an erection</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>relaxed and calm</li>
<li>sleepiness</li>
<li>stomach soreness or discomfort</li>
<li>stuffy nose</li>
<li>weight loss</li>
</ul><p>
<i>Incidence not determined</i>
</p><ul>
<li>Cracks in the skin</li>
<li>discoloration of skin</li>
<li>feeling of constant movement of self or surroundings</li>
<li>increased sensitivity of skin to sunlight</li>
<li>large, flat, blue or purplish patches in the skin</li>
<li>loss of heat from the body</li>
<li>muscle spasm, weakness, or restlessness</li>
<li>scaly skin</li>
<li>sensation of spinning</li>
<li>severe sunburn</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to bendroflumethiazide / nadolol: oral tablet</i></p><h3>Cardiovascular</h3><p>Bendroflumethiazide:</p>
<p><b>Frequency not reported</b>: Necrotizing angiitis, vasculitis, orthostatic hypotension</p>
<p></p>
<p>Nadolol:</p>
<p><b>Common</b> (1% to 10%): Heart rate less than 40 beats per minute (bpm), symptoms of peripheral vascular insufficiency, cardiac failure, hypotension, rhythm/conduction disturbances</p>
<p><b>Frequency not reported</b>: Heart rate less than 60 bpm, first degree heart block, third degree heart block<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Bendroflumethiazide:</p>
<p><b>Frequency not reported</b>: Dizziness, vertigo, paresthesia, headache</p>
<p></p>
<p>Nadolol:</p>
<p><b>Common</b> (1% to 10%): Dizziness/fatigue</p>
<p><b>Uncommon</b> (0.1% to 1%): Paresthesias, sedation, headache, tinnitus, slurred speech<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Bendroflumethiazide:</p>
<p><b>Frequency not reported</b>: Nausea, vomiting, cramping, diarrhea, constipation, gastric irritation, abdominal bloating, sialadenitis, pancreatitis</p>
<p></p>
<p>Nadolol:</p>
<p><b>Uncommon</b> (0.1% to 1%): Nausea, diarrhea, abdominal discomfort, constipation, vomiting, indigestion, bloating, flatulence, dry mouth<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Bendroflumethiazide:</p>
<p><b>Frequency not reported</b>: Purpura, exfoliative dermatitis, pruritus, ecchymosis, urticaria, cutaneous vasculitis, photosensitivity, rash</p>
<p></p>
<p>Nadolol:</p>
<p><b>Uncommon</b> (0.1% to 1%): Rash, pruritus, dry skin, sweating, facial swelling</p>
<p><b>Frequency not reported</b>: Reversible alopecia<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Bendroflumethiazide:</p>
<p><b>Frequency not reported</b>: Respiratory distress, pneumonitis</p>
<p></p>
<p>Nadolol:</p>
<p><b>Uncommon</b> (0.1% to 1%): Bronchospasm, cough, nasal stuffiness<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Bendroflumethiazide:</p>
<p><b>Frequency not reported</b>: Anorexia, hyperglycemia, metabolic acidosis, hyperuricemia</p>
<p></p>
<p>Nadolol:</p>
<p><b>Uncommon</b> (0.1% to 1%): Anorexia, weight gain<sup>[Ref]</sup></p><h3>Ocular</h3><p>Bendroflumethiazide:</p>
<p><b>Frequency not reported</b>: Xanthopsia, transient blurred vision</p>
<p></p>
<p>Nadolol:</p>
<p><b>Uncommon</b> (0.1% to 1%): Dry eyes, blurred vision<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Bendroflumethiazide:</p>
<p><b>Frequency not reported</b>: Restlessness</p>
<p></p>
<p>Nadolol:</p>
<p><b>Uncommon</b> (0.1% to 1%): Change in behavior, impotence or decreased libido<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Bendroflumethiazide:</p>
<p><b>Frequency not reported</b>: Leukopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, aplastic anemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Bendroflumethiazide:</p>
<p><b>Frequency not reported</b>: Intrahepatic cholestatic jaundice, hepatitis<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Bendroflumethiazide:</p>
<p><b>Frequency not reported</b>: Anaphylactic reactions, allergic glomerulonephritis<sup>[Ref]</sup></p><h3>Other</h3><p>Bendroflumethiazide:</p>
<p><b>Frequency not reported</b>: Fever, weakness<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Bendroflumethiazide:</p>
<p><b>Frequency not reported</b>: Glycosuria<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Bendroflumethiazide:</p>
<p><b>Frequency not reported</b>: Muscle spasm<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Corzide (bendroflumethiazide-nadolol)" Bristol-Myers Squibb, Princeton, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Corzide (bendroflumethiazide / nadolol)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Generic Availability</li>
<li>Drug class: beta blockers with thiazides</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Corzide 40/5</li>
<li>Corzide 80/5</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to bendroflumethiazide / nadolol: oral tablet</i></p><h3>Cardiovascular</h3><p>Bendroflumethiazide:</p><p><b>Frequency not reported</b>: Necrotizing angiitis, vasculitis, orthostatic hypotension</p><p></p><p>Nadolol:</p><p><b>Common</b> (1% to 10%): Heart rate less than 40 beats per minute (bpm), symptoms of peripheral vascular insufficiency, cardiac failure, hypotension, rhythm/conduction disturbances</p><p><b>Frequency not reported</b>: Heart rate less than 60 bpm, first degree heart block, third degree heart block<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Bendroflumethiazide:</p><p><b>Frequency not reported</b>: Dizziness, vertigo, paresthesia, headache</p><p></p><p>Nadolol:</p><p><b>Common</b> (1% to 10%): Dizziness/fatigue</p><p><b>Uncommon</b> (0.1% to 1%): Paresthesias, sedation, headache, tinnitus, slurred speech<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Bendroflumethiazide:</p><p><b>Frequency not reported</b>: Nausea, vomiting, cramping, diarrhea, constipation, gastric irritation, abdominal bloating, sialadenitis, pancreatitis</p><p></p><p>Nadolol:</p><p><b>Uncommon</b> (0.1% to 1%): Nausea, diarrhea, abdominal discomfort, constipation, vomiting, indigestion, bloating, flatulence, dry mouth<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Bendroflumethiazide:</p><p><b>Frequency not reported</b>: Purpura, exfoliative dermatitis, pruritus, ecchymosis, urticaria, cutaneous vasculitis, photosensitivity, rash</p><p></p><p>Nadolol:</p><p><b>Uncommon</b> (0.1% to 1%): Rash, pruritus, dry skin, sweating, facial swelling</p><p><b>Frequency not reported</b>: Reversible alopecia<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Bendroflumethiazide:</p><p><b>Frequency not reported</b>: Respiratory distress, pneumonitis</p><p></p><p>Nadolol:</p><p><b>Uncommon</b> (0.1% to 1%): Bronchospasm, cough, nasal stuffiness<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Bendroflumethiazide:</p><p><b>Frequency not reported</b>: Anorexia, hyperglycemia, metabolic acidosis, hyperuricemia</p><p></p><p>Nadolol:</p><p><b>Uncommon</b> (0.1% to 1%): Anorexia, weight gain<sup>[Ref]</sup></p><h3>Ocular</h3><p>Bendroflumethiazide:</p><p><b>Frequency not reported</b>: Xanthopsia, transient blurred vision</p><p></p><p>Nadolol:</p><p><b>Uncommon</b> (0.1% to 1%): Dry eyes, blurred vision<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Bendroflumethiazide:</p><p><b>Frequency not reported</b>: Restlessness</p><p></p><p>Nadolol:</p><p><b>Uncommon</b> (0.1% to 1%): Change in behavior, impotence or decreased libido<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Bendroflumethiazide:</p><p><b>Frequency not reported</b>: Leukopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, aplastic anemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Bendroflumethiazide:</p><p><b>Frequency not reported</b>: Intrahepatic cholestatic jaundice, hepatitis<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Bendroflumethiazide:</p><p><b>Frequency not reported</b>: Anaphylactic reactions, allergic glomerulonephritis<sup>[Ref]</sup></p><h3>Other</h3><p>Bendroflumethiazide:</p><p><b>Frequency not reported</b>: Fever, weakness<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Bendroflumethiazide:</p><p><b>Frequency not reported</b>: Glycosuria<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Bendroflumethiazide:</p><p><b>Frequency not reported</b>: Muscle spasm<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Corzide (bendroflumethiazide-nadolol)" Bristol-Myers Squibb, Princeton, NJ. </p><h2>More about Corzide (bendroflumethiazide / nadolol)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Generic Availability</li>
<li>Drug class: beta blockers with thiazides</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Corzide 40/5</li>
<li>Corzide 80/5</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>